← Browse by Condition
Medical Condition

recurrent multiple myeloma

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT05847569 Phase 2
Recruiting

Alternate Doses and Dosing Schedules of Belantamab Mafodotin for Treatment of Triple-Class Refractory Multiple Myeloma

Enrollment
62 pts
Location
United States
Sponsor
Mayo Clinic
View Trial →